Equity incl. NCI
Balance – as of period end · $M
FY2022
334$M
All values (8)
| Period | Value ($M) | Status |
|---|---|---|
| FY2026 | 2,064 | reported |
| FY2025 | 682 | reported |
| FY2024 | 540 | reported |
| FY2023 | 348 | reported |
| FY2022 | 334 | reported |
| FY2021 | −55 | reported |
| FY2020 | −9 | reported |
| FY2019 | −13 | reported |
| FY2016 – FY2018 | – | missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Credo
Income statement
Balance sheet
Sources & calculation
- Value
- $334M
- Period
- FY2022, ended Apr 30, 2022 · as of Apr 30, 2022 (balance as of date, not a sum)
- Source
- 10-K, filed Jun 8, 2022 · 0001628280-22-016593
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $334M | Jun 8, 2022 | 10-K 0001628280-22-016593 | reported · confidence 1. · current |